Specific removal of ldl from blood
CA 2001358 A1 · Owner: Schonfeld, Gustav · Inventors: Ostlund, Richard E. Jr; Schonfeld, Gustav
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
32-, Abstract, Disclosed herein are particularly efficient methods to reduce cholesterol in patients by treating whole blood with agarose beads conjugated to anti-LDL antibodies or, especially when conjugated through the mediation of an amino functionality, to a polyanionic sulfate. In preferred embodiments, the beads are characterized as comprising 0.5-3% agarose preferably 2%, agarose, and having diameters of 200-300 micron. Preferred antibodies are cross-reactive with C3D1 antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 1989. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.